AstraZeneca strikes $40 million AI drug discovery deal with insitro
Every article the Monitor has on this event, each linked to the outlet that published it. The line above is the headline channelnewsasia.com published, not a summary written here.
Event started Oct 15, 6:03 AM EDT. Newest coverage on file Oct 16, 3:50 AM EDT. No development has been recorded, separate from coverage arriving. This page was last built from a pipeline run at Nov 11, 7:27 AM EST. Grouped by title similarity, assembly s1, merge threshold 0.25. How stories are grouped.
What is on file, and what is not
Three bands, split by what the source is rather than by what it says. The band a piece of coverage lands in comes from a public registry of the domain that published it, not from any reading of the article.
阿斯利康(AZN.US)加入"AI+制药"热潮:18.6亿美元牵手Insitro研发脂肪肝与心肌疾病药物-财经-金融界
ASLICON (AZN.US) joins the "AI+ Pharmaceuticals" boom: $18.6 billion in Insitro to develop fatty liver and heart disease drugs - finance and finance
AstraZeneca setzt auf KI: Kooperation mit Insitro bei der Arzneimittelforschung
AstraZeneca invests in AI: collaboration with Insitro in drug research
Aktie im Plus: AstraZeneca und Insitro vereinbaren KI-Partnerschaft in der Wirkstoffforschung
AstraZeneca and Insitro agree on AI partnership in active substances research
What actually moved
Documents, statements by a named party, and entries an editor has made. Coverage is not a development, and it is kept below.
Nothing here yet. A development is a primary document or a government record arriving, a named party publishing a statement of its own, or an entry an editor has made. Outlets repeating one report are coverage, and they are in the timeline below.
When each outlet carried it
One entry the first time an outlet publishes, and a later entry from the same outlet when it publishes again more than six hours on, which is usually a follow up rather than a repeat. A document is always listed. Times are US Eastern.
AstraZeneca strikes $40 million AI drug discovery deal with insitrochannelnewsasia.com
阿斯利康(AZN.US)加入"AI+制药"热潮:18.6亿美元牵手Insitro研发脂肪肝与心肌疾病药物-财经-金融界finance.jrj.com.cn
AstraZeneca Signs $40 Million insitro AI Research Dealfinchannel.com
People, coverage and context
What changed about this page
Grouping is done by rule and corrected by hand. Every correction an editor makes to this story is listed here with its date.
No corrections have been made to this story. Corrections appear here, dated, when they are.